HE 184/2016 vp StV 27.10.2016 Suomen Apteekkariliitto ry Asiantuntijalausunto

This procedure concerns an expert opinion from the Finnish Pharmacists' Union regarding health insurance, drug reimbursements, wholesale prices, price competition, parallel imports, medicines, waste, diabetes, and businesses. The opinion likely addresses how changes in drug pricing and reimbursement policies might affect Finnish pharmacies, patients, and the pharmaceutical market, particularly concerning generic drugs and waste management.